Nouryon Expands Channel Partnership with IMCD

2023-07-22
Nouryon announced an expansion to its channel partnership with IMCD fir its fuel solutions and lubricant, including the distribution of select Armolube and Armeen additives in Europe and the US.  “This channel partnership with IMCD will enhance the industry’s ability to formulate lubricants and fuels that meet next generation legislation and original equipment manufacturer requirements,” said Nouryon’s Senior Vice President of Natural Resources Joppe Smit. “The recent expansion of our partnership with IMCD allows us to better support customers within automotive and industrial applications in the US and Europe.” The agreement aligns with the company’s strategic focus to partner with market leaders to better serve customers with the development of innovation. Research and development synthesis labs and application centers around the world have been dedicated to supporting surface analysis and innovation.  Nouryon offers includes a brad portfolio of lubricant and fuel additives, frictionless modifiers, grease thickeners, corrosion inhibitors, detergents, and anti-wear components for segments such as industrial, automotive, marine, and metalworking. Its portfolio also includes a selection of ash-free and naturally derived additives to help formulators adhere to new regulations. Global Business Group Director at IMCD Lubricants and Energy Marco Madeddu said, “our partnership with Nouryon reinforces IMCD’s dedication to delivering world-class chemistries and solutions to the lubricants and energy markets. Nouryon’s innovative line of surfactants and polymer solutions complements our comprehensive product portfolio of additives and synthetic base fluids. Our dedicated sales team and technical experts are well-poised to explore new solutions-based opportunities for both Nouryon and our valued customers.”
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。